Enovix has announced a common stock offering worth $100 million, facilitated through Cantor Fitzgerald. The announcement has led to a pre-market decline of 9.4% in Enovix's share price. In a separate development, CalciMedica has also announced a public offering of common stock, which has resulted in a 19.6% pre-market drop in its share price. Additionally, Palladyne AI Corp. has priced a registered direct offering at $7 million, including concurrent private placements. In another offering, Harmony Biosciences has priced an 8 million share offering at $31 per share.